US Pharma MarketingThe post FDA grants clearance for PhenoNet Phase III trial in early Alzheimer’s appeared first on Clinical Trials Arena.
FDA grants clearance for PhenoNet Phase III trial in early Alzheimer’s
PhenoNet has received FDA approval to proceed with a Phase III clinical trial evaluating PHENOGENE-1A in individuals with early Alzheimer’s. The post FDA grants clearance for PhenoNet Phase III trial in early Alzheimer’s appeared first on Clinical Trials Arena .
PhenoNet has received FDA approval to proceed with a Phase III clinical trial evaluating PHENOGENE-1A in individuals with early Alzheimer’s.
Source: Clinical Trials Arena